Applying surgical antimicrobial standards in cesarean deliveries

Area of Science:

• Surgical infection prevention
• Obstetric anesthesia and analgesia
• Pharmacodynamics in surgery

Background:

• Surgical site infections (SSIs) are a significant concern, with antimicrobial prophylaxis being a key risk-reduction strategy.
• Standard practice includes antibiotic redosing for prolonged surgeries or after substantial blood loss (e.g., >1500 mL).
• Existing guidelines from professional associations generally support these redosing principles.

Purpose of the Study:

• To examine current antimicrobial prophylaxis guidelines regarding antibiotic redosing in surgical procedures.
• To review the evidence supporting antibiotic redosing recommendations based on procedure length or blood loss.
• To question the established practice of *not* redosing antibiotics during cesarean deliveries.

Main Methods:

• Review of published guidelines from major surgical and obstetric professional associations.
• Analysis of data and rationale underpinning current redosing recommendations.
• Exploration of infection rates and potential benefits of redosing in the cesarean delivery cohort.

Main Results:

• Most guidelines recommend antibiotic redosing after 2 drug half-lives or estimated blood loss exceeding 1500 mL.
• Cesarean delivery is a notable exception where routine redosing is often not practiced.
• This practice persists despite considerable SSI burden in cesarean delivery patients.

Conclusions:

• Current antibiotic redosing guidelines are not uniformly applied across all surgical specialties.
• The lack of redosing in cesarean deliveries warrants re-evaluation given the associated infection risks.
• Further investigation into the efficacy and safety of redosing antibiotics in cesarean deliveries is needed.